An International Journal Clinical Rhinology

Register      Login

VOLUME 2 , ISSUE 3 ( September-December, 2009 ) > List of Articles


Invasive Sino-aspergillosis in Immunocompetent Individuals: Atypical Presentations

Zareen A Lynrah, Gopika Kalsotra

Keywords : Invasive aspergillosis,isolated sinus involvement,Voriconazole

Citation Information : Lynrah ZA, Kalsotra G. Invasive Sino-aspergillosis in Immunocompetent Individuals: Atypical Presentations. Clin Rhinol An Int J 2009; 2 (3):27-32.

DOI: 10.5005/jp-journals-10013-1006

Published Online: 01-12-2009

Copyright Statement:  Copyright © 2009; The Author(s).



To describe the demographic, clinical and radiological findings of invasive aspergillosis of the orbit and paranasal sinuses in immunocompetent individuals that presented without any nasal symptoms and to review the role of voriconazole in such cases.

Materials and methods

A series of 13 cases is being reported with review of literature. All these cases except one underwent complete surgical debridement of the disease at the time of biopsy. On histopathological confirmation of invasive aspergillosis, the cases with sphenoid sinus involvement were given 2.5 gm of intravenous Amphotericin B (1 mg/kg/day) followed by oral itraconazole in a dose of 10 mg/kg/day for 6 months. The cases where there were lesser chances of intracranial involvement or the cases that refused for intravenous Amphotericin B were started on voriconazole 200 mg twice a day for six to twelve months. All these cases were followed up with the help of radiology, clinical improvement in symptoms and signs and fungal serology.


We found isolated sphenoid sinus involvement in 10 (76.92%) cases, isolated maxillary sinus involvement 2 (15.38%) cases and isolated orbital involvement 1 (7.69%). Our protocol was successful in 11 (84.61%) cases, one patient was lost to follow-up while one died due to intracranial complications during the third week of therapy.


This study showcased the atypical presentations of invasive aspergillosis in immunocompetent individuals and the high degree of suspicion required to diagnose this entity. An aggressive, effective and optimal management protocol has been suggested and the role of voriconazole has been highlighted.

PDF Share
  1. Aspergilloma of paranasal sinuses and orbit in Northern Sudanese. Lancet 1966;1:746-47.
  2. Paranasal sinus mycoses in north India. Mycoses 1998;41:281-86.
  3. Postoperative responses of paranasal Aspergillus granuloma to itraconazole. Trans R Soc Trop Med Hyg 1992;86:93-94.
  4. Nasosinusal fungal granuloma: Clinical profile. Singapore Med 1996;J 37:470-74.
  5. Cranial and intracranial aspergillosis of sinonasal origin. Report of nine cases. Acta Neurochir (Wien) 1996;138:944-50.
  6. Sinonasal aspergillosis in immunocompetent Indian children: An eight-year experience. Mycoses 2003;46:455-61.
  7. Pathology consultation: Sinus aspergillosis and allergic fungal sinusitis. Ann Otol Rhinol Laryngol 1991;100:427-30.
  8. Invasive sinus aspergillosis in apparently immunocompetent hosts. J Infect 1998;37:229-40.
  9. Invasive sino-orbital aspergillosis: Surgical decisions and dilemmas. J Laryngol Otol 2003;117:280-85.
  10. Isolated sphenoid sinus disease: An analysis of 132 cases. Laryngoscope 1997;107:1590-95.
  11. Isolated sphenoid sinus lesions. Laryngoscope 1973;83:1252-65.
  12. Host defense mechanism in aspergillus fumigatus infections. Contrib Microbiol 1996;9:469-88.
  13. Fulminant aspergillosis of the nose and paranasal sinuses: A new clinical entity. Laryngoscope 1980;90:748-54.
  14. Aspergillosis of the orbit: Report of ten cases and review of the literature. Arch Ophthalmol 1969;82:302-13.
  15. Use of amphotericin B with azole anti-fungal drugs; What are we doing? Anti Microb Agents Chemother 1995;39(9):1907-12.
  16. Amphotericin B with and without itraconazole for invasive aspergillosis. A three year retrospective study. Int J Infect Dis 1999;3(3):157-60.
  17. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994;97:135-44.
  18. Combination Therapy for Aspergillosis. Clinical Infectious Diseases 2004; 39:797-802.
  19. Voriconazole: A new triazole antifungal. Ann Pharmacother 2000; 34:1032-43.
  20. In vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B. J Antimicrob Chemother 1998; 42:91-94.
  21. Adverse reactions to voriconazole. Clin Infect Dis 2004;39:1241-44.
  22. Invasive rhinosino-orbital aspergillosis with precipitous visual loss. Can J Ophthalmol 1995;30:124-30.
  23. Invasive aspergillosis of the paranasal sinuses and orbit: Can you save the eye? Am J Otolaryngol 1997;18:230-34.
  24. Postgraduate institute management protocol for invasive Aspergillus flavus sinusitis: Is it effective? Int J of Inf Dis 13(2):134-39.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.